• Dexcom: Glucose monitoring doubles when diabetics take weight loss drugs

    Type 2 diabetes patients who take a GLP-1 such as Ozempic or Wegovy are associated with higher usage of continuous glucose monitors, Dexcom said Sept. 5, according to an Investor's Business Daily report.
  • How does your system manage rare disease patients? Becker's wants to hear.

    Sponsored
    Fill out this short survey here and attend our annual meeting for free.
  • Colorado drugmaker to shutter operations

    Aktiv Pharma Group, a drugmaker based in Broomfield, Colo., plans to shut down two of its three plants and lay off 70 workers, according to multiple news outlets. 
  • Mark Cuban's pharmacy to sell COPD generic + 4 updates

    Lupin, a Mumbai, India-based drug company, is collaborating with Mark Cuban Cost Plus Drug Co. to sell its generic chronic obstructive pulmonary disease drug through the mail-order pharmacy. 
  • Ozempic, Wegovy enter trials for treating addiction, dementia

    Researchers in the U.S. and U.K. are testing Type 2 diabetes drug Ozempic and weight loss therapy Wegovy for their potential in diminishing dementia and addiction, CNBC reported Sept. 7. 
  • California pharmacists make 5 million mistakes every year: Report

    Pharmacists are overworked and understaffed, according to the California Board of Pharmacy, and it may be what is leading them to make up to 5 million errors each year, the Los Angeles Times reported Sept. 5.
  • New COVID-19 boosters: 3 things to know

    Amid a late-summer increase in COVID-19 cases and hospitalizations, the next booster shot targeting XBB.1.5 might be available as early as Sept. 13. 
  • The 340B repayments 100 hospitals are set to receive 

    CMS bookmarked $9 billion for the 2,600 340B hospitals to repay unlawful payment cuts, and nearly half, $4.3 billion, is planned for 100 of those hospitals, according to data from the Community Oncology Alliance. 
  • UPMC held an equity lottery for sparse COVID-19 drugs

    When UPMC was short on COVID-19 monoclonal antibody Evusheld, the Pittsburgh-based system assembled a weighted lottery for equitable care, according to a study published Sept. 1 in JAMA. 
  • FDA to reward drugmakers investing in quality measures

    As quality issues remain as the main reason drugs fall into shortages, the FDA unveiled a plan to incentivize drugmakers to invest in quality measures, according to a white paper.
  • The 'Where's Waldo?' of pharmacy tech

    Besides AI, one emerging technology is snatching the attention of Joe Burczynski, PharmD, which performs tasks in a manner similar to completing a "Where's Waldo?" game with immediate success.
  • Alabama hospital names Dr. Amy Holland as pharmacy director

    D.W. McMillan Memorial Hospital in Brewton, Ala., chose Amy Holland, PharmD, as its pharmacy director, according to an Aug. 28 news release.
  • Wasted antibiotics cost 3 children's hospitals $230K

    An average of 80 antibiotic doses were wasted daily at Children's Healthcare of Atlanta between 2020 and 2021, which cost the system about $233,000, according to a study conducted by employees of the three-hospital system and Atlanta-based Emory University. 
  • Walmart denies claims it asked pharmacists to take pay cuts

    Walmart allegedly urged its leaders to ask some of the company's 16,000 pharmacists to voluntarily reduce their working hours, Reuters reported Aug. 29. The company rebuffed these claims. 
  • Erlanger taps specialty pharmacy partner

    Chattanooga, Tenn.-based Erlanger Health System partnered with Shields Health Solutions, a specialty pharmacy business owned by Walgreens, to build a new specialty pharmacy program. 
  • Pfizer eyes reopening North Carolina plant by Q4

    After a tornado damaged one of the largest sterile injectable drug manufacturing facilities in the world, Pfizer predicted the Rocky Mount, N.C., plant will be producing again in the next few months.
  • CMS names 10 drugs for price negotiations

    Four Type 2 diabetes drugs are in CMS' lineup of the 10 drugs that face price negotiations between the agency and their makers. 
  • New RSV shot costs $330 for some adults

    Some payers aren't covering the recently approved vaccines for respiratory syncytial virus, leaving older adults to cough up $330 out of pocket, The New York Times reported Aug. 25. 
  • 14 drugs now in shortage

    While some hospitals are paying five to 10 times more for cancer drugs during a monthslong shortage, the U.S. saw 14 new drug supply issues since early August. 
  • Philadelphia hospital taps pharmacy director

    Philadelphia-based Fox Chase Cancer Center named Dapo Amosu, PharmD, as its senior pharmacy director. 
  • Rite Aid to file for bankruptcy: Report

    Rite Aid is preparing to file for Chapter 11 bankruptcy this fall as it faces numerous lawsuits over its alleged role in the opioid epidemic, people familiar with the matter told The Wall Street Journal. 

Featured Whitepapers

Featured Webinars